Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Conde

Showing results (71-80 of 75) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 75 results.
Neuromuscular Disorders : NMD|June 26, 2007
The DUX4 gene at the FSHD1A locus encodes a pro-apoptotic proteinValeria Kowaljow, Aline Marcowycz, Eugénie Ansseau, et al.
The New England Journal of Medicine|December 14, 2011
Three months of rifapentine and isoniazid for latent tuberculosis infectionTimothy R Sterling, M Elsa Villarino, Andrey S Borisov, et al.
Plos One|May 10, 2016
A Phase 2 Randomized Trial of a Rifapentine plus Moxifloxacin-Based Regimen for Treatment of Pulmonary TuberculosisMarcus B Conde, Fernanda C Q Mello, Rafael Silva Duarte, et al.
Plos One|February 13, 2023
A study about management of drugs for leprosy patients under medical monitoring: A solution based on AHP-Electre decision-making methodsIgor W S Falcão, Daniel S Souza, Diego L Cardoso, et al.
Pulmonology|November 27, 2018
Portuguese consensus document for the management of alpha-1-antitrypsin deficiencyA P Lopes, M A Mineiro, F Costa, et al.
Pageof 8

Showing results (71-80 of 75) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 75 results.
Neuromuscular Disorders : NMD|June 26, 2007
The DUX4 gene at the FSHD1A locus encodes a pro-apoptotic proteinValeria Kowaljow, Aline Marcowycz, Eugénie Ansseau, et al.
The New England Journal of Medicine|December 14, 2011
Three months of rifapentine and isoniazid for latent tuberculosis infectionTimothy R Sterling, M Elsa Villarino, Andrey S Borisov, et al.
Plos One|May 10, 2016
A Phase 2 Randomized Trial of a Rifapentine plus Moxifloxacin-Based Regimen for Treatment of Pulmonary TuberculosisMarcus B Conde, Fernanda C Q Mello, Rafael Silva Duarte, et al.
Plos One|February 13, 2023
A study about management of drugs for leprosy patients under medical monitoring: A solution based on AHP-Electre decision-making methodsIgor W S Falcão, Daniel S Souza, Diego L Cardoso, et al.
Pulmonology|November 27, 2018
Portuguese consensus document for the management of alpha-1-antitrypsin deficiencyA P Lopes, M A Mineiro, F Costa, et al.
Pageof 8